SCHEMBL7420037

SCHEMBL7420037

CNc1ccc(C(NC(=O)OC(C)(C)C)C(=O)N2CCCC2)cc1NC(=O)CNc1ccc(C#N)cc1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
PKM P14618 1/20 0.37
FPR1 P21462 4/20 0.37
FPR2 P25090 4/20 0.37
CTSK P43235 2/20 0.36
CTSS P25774 1/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
PABPC1 P11940 1/20 0.35
CTSL P07711 1/20 0.35
CTSB P07858 1/20 0.35
DRD2 P14416 1/20 0.34
KDM4D Q6B0I6 1/20 0.33
EGLN2 Q96KS0 1/20 0.33
CETP P11597 2/20 0.33
HRH2 P25021 1/20 0.33
HRH1 P35367 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7420806 0.82 ALDH1A1 (0.38) ALDH1A1PKMFPR1FPR2MEN1
SCHEMBL7411883 0.75 AAK1 (0.41) CTSKCTSSCTSLCTSB
SCHEMBL7412573 0.72 ALDH1A1 (0.42) ALDH1A1PKMMEN1KMT2AGAA
SCHEMBL7421439 0.72 HCAR3 (0.40) ALDH1A1PKMCTSKCTSSMEN1
SCHEMBL5151249 0.68 FPR2 (0.59) FPR1FPR2CTSKCTSSKMT2A
SCHEMBL6767381 0.68 FPR2 (0.59) FPR1FPR2CTSKCTSSKMT2A
SCHEMBL5155529 0.68 FPR2 (0.59) FPR1FPR2CTSKCTSSKMT2A
SCHEMBL21468963 0.68 CTSK (0.43) CTSKCTSSMEN1KMT2ACTSL
SCHEMBL16379880 0.68 CTSK (0.43) CTSKCTSSMEN1KMT2ACTSL
SCHEMBL21469088 0.68 MTTP (0.37) CTSKCTSSMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1095025-B1 BENZIMIDAZOLES, PRODUCTION THEREOF AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2002-12-11 EP disclosed
US-6248770-B1 CARDIOVASCULAR DISORDERS BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-06-19 US disclosed